Devices (same UDI-DI)
1
Certificates
0
Countries
13
Notified Bodies
0
Basic Information
- Primary DI
- 03701077400454
- Basic UDI-DI Code
- B-03701077400454
- Reference
- NGB-COV-S23-024
- Device Types
-
Single use
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- On The Market
- Manufacturer
- NG Biotech
Additional Description
The NG-Test® SARS-CoV-2 Ag is an immunochromatographic assay for the qualitative detection of SARS-CoV-2 antigen in nasopharyngeal specimens. The NG-Test® SARS-CoV-2 Ag is for professional use only and is intended for use as an aid in the diagnosis of SARS-CoV-2 infection.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W0105099099 | VIROLOGY - RT & POC - OTHER |
Available In Countries
🇧🇪 Belgium
🇨🇿 Czechia
🇩🇪 Germany
🇪🇸 Spain
🇫🇮 Finland
🇫🇷 France
🇮🇪 Ireland
🇮🇹 Italy
🇳🇱 Netherlands
🇵🇱 Poland
🇵🇹 Portugal
🇸🇪 Sweden
🇬🇧 United Kingdom
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).
BluBox
Device
EU IVDD
·
Eu Ivd General
·Blusense Diagnostics ApS·On the market·5 countries
extendSURE™ HbA1c Liquid Controls
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·19 countries
ViroTrack Sero COVID-19 Total Ab
Device
EU IVDD
·
Eu Ivd General
·Blusense Diagnostics ApS·On the market·5 countries
extendSURETM Haemoglobin F and A2 Calibrators
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·8 countries
extendSURE™ Haemoglobin F and A2 Controls
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·8 countries
extendSURE™ HbA1c Liquid Controls
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·19 countries